<DOC>
	<DOCNO>NCT00997581</DOCNO>
	<brief_summary>The purpose study learn possible new medicine , apremilast , treat acute gout compare work indomethacin , medication use treat gout 50 year . In order learn apremilast , half participant study receive apremilast half participant study receive indomethacin . This study measure severity duration acute gout attack research participant , well measure quality life side effect adverse reaction medication . There three study visit : screening/baseline visit Day 1 , visit evaluate response treatment study medication Day 7 , follow-up visit Day 21 .</brief_summary>
	<brief_title>Apremilast Therapy Acute Gouty Arthritis</brief_title>
	<detailed_description>WITHDRAWN</detailed_description>
	<mesh_term>Arthritis , Gouty</mesh_term>
	<mesh_term>Apremilast</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Must understand voluntarily sign informed consent Must diagnosis gout proven identification urate crystal body fluid Must male age &gt; 18 year time consent Must able adhere study visit schedule protocol requirement Must meet follow laboratory criterion : Hemoglobin &gt; 9.0 g/dL White blood cell ( WBC ) count &gt; 3000/μL &lt; 14,000/μL Platelet count &gt; 100,000/μL Serum creatinine &lt; 2.0mg/dL Total bilirubin &lt; 2.0 mg/dL Aspartate transaminase ( AST ) alanine transaminase ( ALT ) &lt; 1.5 X upper limit normal Males , include vasectomy , must agree use barrier contraception ( latex condom ) engage sexual activity female childbearing potential ( FCBP ) study medication 84 day take last medication Inability provide voluntary consent Any condition , include presence laboratory abnormality , place subject unacceptable risk participate study confound ability interpret data study Females Systemic fungal infection History recurrent bacterial infection ( least 3 major infection result hospitalization and/or require intravenous antibiotic treatment past 2 year An active infection presentation Use investigational medication within 4 week prior start study 5 pharmacokinetic/pharmacodynamic halflives , whichever longer Any use corticosteroid , cyclosporine , methotrexate , cyclophosphamide , azathioprine , mycophenolate within 4 week prior start study Any clinically significant abnormality 12lead ECG screen Malignancy history malignancy ( except treat cure basalcell skin carcinoma &gt; 3 year prior screen )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Gout</keyword>
</DOC>